Microbot Medical Inc. insider trading

Every open-market purchase and sale by Microbot Medical Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Microbot Medical Inc.’s insiders pay?

From March 18, 2010 to December 6, 2017, 7 insiders reported 1 open-market purchase and 12 sales not made under a pre-set plan in Microbot Medical Inc.

Microbot Medical Inc.: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Bornstein Yoseph	Director	0	—	—	5	—	September 20, 2017
Stratton Kenneth Blair	General Counsel	0	—	—	2	—	December 30, 2015
Waizer Yoav Zvi	Director	1	—	—	1	—	December 6, 2017
Koshy George	Other	0	—	—	1	—	March 18, 2010
Lewkowicz Leon	10% owner	0	—	—	1	—	June 20, 2017
Tsukamoto Ann	EVP, Research and Development	0	—	—	1	—	May 20, 2011
Young Rodney Kb	CFO	0	—	—	1	—	March 18, 2010

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Microbot Medical Inc. · Funds · Politicians